Literature DB >> 25597022

Extent of late gadolinium enhancement at right ventricular insertion points in patients with hypertrophic cardiomyopathy: relation with diastolic dysfunction.

Yinsu Zhu1, Eun-Ah Park, Whal Lee, Hyung-Kwan Kim, Ajung Chu, Jin Wook Chung, Jae Hyung Park.   

Abstract

OBJECTIVES: Our aim was to examine the association between the extent of late gadolinium enhancement (LGE) at right ventricular insertion points (RVIP) and left ventricular (LV) functional parameters in patients with hypertrophic cardiomyopathy (HCM).
METHODS: Sixty-one HCM patients underwent echocardiography and cardiovascular magnetic resonance (CMR) within one week. Mitral annular velocities (E/E') were obtained from echocardiography; LV ejection fraction (EF), LV mass index, LV wall maximal thickness, and left atrial volume index (LAVI) were obtained from MR. LGE extent was quantified (proportion of total LV myocardial mass) according to location: % RVIP-LGE and % non-RVIP-LGE.
RESULTS: Although LGE was commonly present in both apical (74 %) and non-apical HCMs (88 %) (p = 0.163), RVIP-LGE was more frequent (86 % vs. 47 %, p = 0.002) in non-apical HCMs in which E/E' was significantly higher (19.23 ± 8.40 vs. 13.13 ± 5.06, p = 0.009). In addition, RVIP-LGE extent was associated with LV diastolic dysfunction (r = 0.45, p < 0.001 for E/E'; r = 0.53, p < 0.001 for LAVI) and lower LVEF (r = -0.42, p = 0.001). There was no correlation between non-RVIP-LGE extent and other parameters. Multiple linear regression analysis revealed RVIP-LGE extent as an independent predictor of E/E' (β = 0.45, p < 0.001) and LAVI in HCM patients (β = 0.53, p < 0.001).
CONCLUSIONS: The extent of LGE at RVIPs in HCM patients is associated with increased estimated LV filling pressure and chronic diastolic burden. KEY POINTS: • Late gadolinium enhancement at RV insertion points is frequently seen in HCM. • RVIP-LGE extent is correlated with increased estimated LV filling pressure in HCM. • Non-RVIP-LGE extent did not show any association with LV diastolic dysfunction.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25597022     DOI: 10.1007/s00330-014-3390-8

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  45 in total

1.  Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study.

Authors:  S R Ommen; R A Nishimura; C P Appleton; F A Miller; J K Oh; M M Redfield; A J Tajik
Journal:  Circulation       Date:  2000-10-10       Impact factor: 29.690

2.  Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension.

Authors:  Kevin G Blyth; Bjoern A Groenning; Thomas N Martin; John E Foster; Patrick B Mark; Henry J Dargie; Andrew J Peacock
Journal:  Eur Heart J       Date:  2005-05-17       Impact factor: 29.983

Review 3.  Expanding role of cardiovascular magnetic resonance in left and right ventricular diastolic function.

Authors:  Vikas K Rathi; Robert W W Biederman
Journal:  Heart Fail Clin       Date:  2009-07       Impact factor: 3.179

4.  Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy.

Authors:  Martin S Maron; Evan Appelbaum; Caitlin J Harrigan; Jacki Buros; C Michael Gibson; Connie Hanna; John R Lesser; James E Udelson; Warren J Manning; Barry J Maron
Journal:  Circ Heart Fail       Date:  2008-06-23       Impact factor: 8.790

5.  Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy.

Authors:  S F Nagueh; N M Lakkis; K J Middleton; W H Spencer; W A Zoghbi; M A Quiñones
Journal:  Circulation       Date:  1999-01-19       Impact factor: 29.690

6.  Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population.

Authors:  B J Maron; I Olivotto; P Spirito; S A Casey; P Bellone; T E Gohman; K J Graham; D A Burton; F Cecchi
Journal:  Circulation       Date:  2000-08-22       Impact factor: 29.690

7.  Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy.

Authors:  Oliver Bruder; Anja Wagner; Christoph J Jensen; Steffen Schneider; Peter Ong; Eva-Maria Kispert; Kai Nassenstein; Thomas Schlosser; Georg V Sabin; Udo Sechtem; Heiko Mahrholdt
Journal:  J Am Coll Cardiol       Date:  2010-06-25       Impact factor: 24.094

8.  Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy.

Authors:  Paola Melacini; Cristina Basso; Annalisa Angelini; Chiara Calore; Fabiana Bobbo; Barbara Tokajuk; Nicoletta Bellini; Gessica Smaniotto; Mauro Zucchetto; Sabino Iliceto; Gaetano Thiene; Barry J Maron
Journal:  Eur Heart J       Date:  2010-05-31       Impact factor: 29.983

9.  Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension.

Authors:  Benjamin H Freed; Mardi Gomberg-Maitland; Sonal Chandra; Victor Mor-Avi; Stuart Rich; Stephen L Archer; E Bruce Jamison; Roberto M Lang; Amit R Patel
Journal:  J Cardiovasc Magn Reson       Date:  2012-02-01       Impact factor: 5.364

10.  Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy.

Authors:  Iacopo Olivotto; Franco Cecchi; Roberto Gistri; Roberto Lorenzoni; Giampaolo Chiriatti; Francesca Girolami; Francesca Torricelli; Paolo G Camici
Journal:  J Am Coll Cardiol       Date:  2006-03-07       Impact factor: 24.094

View more
  8 in total

1.  Correlation of left ventricular dyssynchrony on gated myocardial perfusion SPECT analysis with extent of late gadolinium enhancement on cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.

Authors:  Hideaki Yuki; Daisuke Utsunomiya; Shinya Shiraishi; Seiji Takashio; Fumi Sakamoto; Noriko Tsuda; Seitaro Oda; Masafumi Kidoh; Takeshi Nakaura; Kenichi Tsujita; Yasuyuki Yamashita
Journal:  Heart Vessels       Date:  2017-12-11       Impact factor: 2.037

2.  Early segmental relaxation abnormalities in hypertrophic cardiomyopathy for differential diagnostic of patients with left ventricular hypertrophy.

Authors:  Christian Voigt; Julia Münch; Maxim Avanesov; Anna Suling; Katrin Witzel; Gunnar Lund; Monica Patten
Journal:  Clin Cardiol       Date:  2017-07-24       Impact factor: 2.882

Review 3.  Multimodality imaging approach to cardiac amyloidosis: part 2.

Authors:  Jacqueline Sennott; Karthikeyan Ananthasubramaniam
Journal:  Heart Fail Rev       Date:  2021-10-25       Impact factor: 4.654

4.  Native T1 mapping and extracellular volume fraction measurement for assessment of right ventricular insertion point and septal fibrosis in chronic thromboembolic pulmonary hypertension.

Authors:  Fritz C Roller; Christoph Wiedenroth; Andreas Breithecker; Christoph Liebetrau; Eckhard Mayer; Christian Schneider; Andreas Rolf; Christian Hamm; Gabriele A Krombach
Journal:  Eur Radiol       Date:  2016-09-20       Impact factor: 5.315

5.  Potential Value of Native T1 Mapping in Symptomatic Adults with Congenital Heart Disease: A Preliminary Study of 3.0 Tesla Cardiac Magnetic Resonance Imaging.

Authors:  Yumi Shiina; Kei Inai; Kota Taniguchi; Tatsunori Takahashi; Michinobu Nagao
Journal:  Pediatr Cardiol       Date:  2019-10-25       Impact factor: 1.655

Review 6.  Cardiac magnetic resonance imaging in the evaluation of patients with hypertrophic cardiomyopathy.

Authors:  Juan Carlos Brenes; Adelina Doltra; Susanna Prat
Journal:  Glob Cardiol Sci Pract       Date:  2018-08-12

7.  Myocardial characterization in pre-dialysis chronic kidney disease: a study of prevalence, patterns and outcomes.

Authors:  Anna M Price; Manvir K Hayer; Ravi Vijapurapu; Saad A Fyyaz; William E Moody; Charles J Ferro; Jonathan N Townend; Richard P Steeds; Nicola C Edwards
Journal:  BMC Cardiovasc Disord       Date:  2019-12-16       Impact factor: 2.298

Review 8.  Major Clinical Issues in Hypertrophic Cardiomyopathy.

Authors:  Hyung-Kwan Kim; Sang Chol Lee; Hyun-Jung Lee; Jihoon Kim; Sung-A Chang; Yong-Jin Kim
Journal:  Korean Circ J       Date:  2022-08       Impact factor: 3.101

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.